RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..7 of 7 - per page
Order by
Treatment and Diagnosis of Cancer, Diabetes and Other Disorders Using Adrenomedullin Peptides and Antibodies
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis)
Novel agents that can interfere with the action of nuclear hormone receptors More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Inno-C08001 (Carvedilol CR)
Inno-C08001 is indicated for the treatment of hypertension, heart failure and left ventricular dysfunction following myocardial infarction More
Stabilisation of biopharmaceuticals
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Optimised pulmonary/nasal therapies using supercritical fluid particle engineering
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..7 of 7 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
CV & Diabetes Market Forecast
Jan 2009 - $15,200
Cardiovascular and metabolic market overview forecast model
Jan 2010 - $15,200
Epidemiology: Hypertension – Rising with increasing obesity and population growth
Oct 2011 - 44 pages - $5,700
Cardiovascular Generic Drugs: Prospects and Opportunities to 2012
Dec 2007 - 186 pages - $3,140
Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit from Huge Market Opportunity in Structural Heart Defects and Vascular Abnormalities
Jul 2010 - 6 pages - $500
Cardiovascular Drug Discoveries 2008
Apr 2008 - 314 pages - $3,140
Transcatheter Cardiovascular Therapeutics (TCT) 2009: Conference Review and Analysis
Oct 2009 - 40 pages - $1,000
Australia Cardiovascular Devices Market Analysis and Forecasts to 2015
Jul 2009 - 279 pages - $3,500
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
Cardiovascular Devices – Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
Sep 2010 - 82 pages - $3,500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us